Validation of the Neurological Fatigue Index for stroke (NFI-Stroke)
© Mills et al.; licensee BioMed Central Ltd. 2012
Received: 13 October 2011
Accepted: 26 April 2012
Published: 15 May 2012
Fatigue is a common symptom in Stroke. Several self-report scales are available to measure this debilitating symptom but concern has been expressed about their construct validity.
To examine the reliability and validity of a recently developed scale for multiple sclerosis (MS) fatigue, the Neurological Fatigue Index (NFI-MS), in a sample of stroke patients.
Six patients with stroke participated in qualitative interviews which were analysed and the themes compared for equivalence to those derived from existing data on MS fatigue. 999 questionnaire packs were sent to those with a stroke within the past four years. Data from the four subscales, and the Summary scale of the NFI-MS were fitted to the Rasch measurement model.
Themes identified by stroke patients were consistent with those identified by those with MS. 282 questionnaires were returned and respondents had a mean age of 67.3 years; 62% were male, and were on average 17.2 (SD 11.4, range 2–50) months post stroke. The Physical, Cognitive and Summary scales all showed good fit to the model, were unidimensional, and free of differential item functioning by age, sex and time. The sleep scales failed to show adequate fit in their current format.
Post stroke fatigue appears to be represented by a combination of physical and cognitive components, confirmed by both qualitative and quantitative processes. The NFI-Stroke, comprising a Physical and Cognitive subscale, and a 10-item Summary scale, meets the strictest measurement requirements. Fit to the Rasch model allows conversion of ordinal raw scores to a linear metric.
Fatigue is a common symptom in stroke [1, 2]. It can be considered to be ‘a feeling of early exhaustion, weariness and aversion to effort’ , or a ‘lack of energy with an increased need to rest’ . The extent of fatigue has been shown to increase with stroke severity. It can have a considerable impact upon lifestyle and has, for example, been shown to be an independent predictor for the need to move into an institutional setting post-stroke . It has also been shown to have association with depression, and sleeping problems .
Given the importance of post-stroke fatigue, several fatigue scales have been used to ascertain the extent of fatigue experienced. Examples include the Fatigue Assessment Scale ; the Multidimensional Fatigue Inventory (MFI-20)  the Fatigue Severity Scale ; and the Brief Fatigue Inventory . A recent review of some of these scales suggested varying levels of reliability and validity, with no one scale showing satisfactory results across all psychometric quality indicators . Consequently it has been argued that a more exact definition of fatigue is needed, and then more valid scales or other technical instruments to quantify fatigue . One such scale, the Neurological Fatigue Index (NFI-MS), was developed from theory and the experiences of those with multiple sclerosis [14, 15].
This current paper sets out to examine if the thematic structure relating to fatigue which emerged from that MS study is also consistent with those who have experienced a stroke, and to test the reliability and validity of the NFI-MS in stroke (any valid subscales would then also be known as NFI-Stroke).
The study had approval from the local research ethics committee (Sefton EC115.03 and 05/Q1501/24). All subjects received written information on the study and gave written informed consent prior to participation.
Sample and materials
Qualitative construct validation
Semi-structured interviews with stroke patients were used to identify the features which defined the concept of fatigue. Subjects with radiologically confirmed stroke were recruited, non-purposively, to undergo a semi-structured interview, as they attended the out patient clinic in the Department of Medicine for the Elderly at University Hospitals Aintree, Liverpool and the Neurology Rehabilitation Unit, Walton Centre for Neurology and Neurosurgery, Liverpool, UK. Patients were excluded if they either had marked impairment of communication or they had another neurological condition. The same interviewer (SD), blinded to the results of the NFI-MS, was used throughout and the face-to-face interviews audio-taped and later transcribed. The ‘framework approach’  was used for the qualitative analysis of the interview transcripts. This part of the study mirrored the qualitative work which had already been undertaken in forty patients with multiple sclerosis and which formed the basis of the NFI-MS; the method is described in detail elsewhere .
The post-stroke qualitative analysis was examined for thematic equivalence against the MS data. It was decided a priori that if post-stroke fatigue was found to be qualitatively identical to MS fatigue, then the existing NFI-MS item set would be used, otherwise further interviews would be undertaken, and new items would be generated to represent any stroke-specific features of fatigue.
The NFI-MS consists of 23 items in four subscales of Physical (8 items), Cognitive (4 items), Relief by diurnal sleep or rest (6 items) and Abnormal nocturnal sleep and sleepiness (5 items). A 10-item Summary Scale derived from physical and cognitive items is also available. Wording of the scales is both simple and concise; the use of the word ‘fatigue’ was deliberately avoided because of its associated semantic ambiguities. All items are worded in such a way as to be scored in the same direction. Each item has a four point, Likert response option  with headings of ‘strongly disagree’, ‘disagree’, ‘agree’ and ‘strongly agree’, which progress in the natural reading direction (i.e. left to right), and are scored 0, 1, 2, 3. There is a single sentence instruction at the start of the scale asking respondents to consider their experience over the previous four weeks.
A pack containing the NFI-MS, other measures and questions on demographics and basic disease information, was mailed to a random cross-section of stroke patients identified from the Aintree Stroke Register held at the University Hospital Aintree, Liverpool, UK. All patients had one or more radiologically confirmed stroke(s) in the previous 50 months. The type of stroke (ischaemic or intracerebral haemorrhage) was known from the stroke register but the Oxfordshire Community Stroke Project subtype  was not available. There were 4,276 patients in the registry with the clinical and demographic details having been obtained prospectively during admission to hospital.
The Fatigue Severity Scale (FSS) , a nine item scale with a seven-point response option, was co-administered as a comparator measure. The FSS is the most frequently used scale in stroke fatigue . In addition, a 10 cm, modified, vertical, visual analogue scale (VAS) with anchors of ‘lively and alert’ and ‘absolutely no energy to do anything at all’ was co-administered; similar vertical visual analogue scales have been widely used [20, 21].
Estimation of disability was made by administration of the Stroke Impact Scale-16 (SIS) . This is a short form version of the Stroke Impact Scale v2.0 . with items based on mobility and activities of daily living, each having a 5-point Likert response; minimum possible score was zero (no meaningful disability) and the maximum was 64. Hemianopia and visual neglect, which might interfere with completion the response option, were assessed by copy of a clock face.
In total, 999 people received the pack. Retesting was performed at 2 to 4 weeks on the first 80 respondents to the main mailout; estimates of the level of fatigue would be correlated between initial and retest time points accepting a Spearman’s rho of ≥0.7. Invariance of mean person estimates at each time point would be confirmed by paired t-test. For analysis of the Rasch fit criteria, only the initial time point data and not the retest data, were included. Data were transcribed to a computer database (transcription error based on checking a random 10% sample was <0.1%, missing data accounted for 3.8% of total).
If the response to the mailout was less than 50%, then non-response bias would be assessed by t-test or chi square comparison for: age at onset of most recent stroke, sex, previous stroke, previous transient ischaemic attack (TIA) and stroke type. This would be performed to exclude any gross bias in the responders, but it must be stressed that population representativeness is not a requirement for Rasch analysis, but rather a wide range of person ‘ability’ (in this case levels of fatigue) is needed .
Quantitative psychometric analysis
Measurement and the rasch model
The internal construct validity of the NFI-MS in stroke was examined by fit of data to the Rasch measurement model . Full details of the process of Rasch analysis are given elsewhere [25, 26]. Briefly, the process is concerned with whether or not the data meets the model expectations, and provides an assessment of the suitability of the response scale, the fit of individual items, differential item functioning, and the dimensionality and targeting of the scale as a whole.
ordered item category thresholds;
both total chi-square probability and individual item chi-square probability values non-significant (5% alpha with Bonferroni correction for the number of items);
individual item fit residual, by convention, within ±2.5;
mean and SD of both item fit residual and person fit residual approaching 0 and 1 respectively;
person-item separation index (PSI) (reliability) greater than 0.70 for group use and 0.85 for individual use;
ANOVA probability for differential item functioning (DIF) non-significant (5% alpha with Bonferroni correction) for the following factors: sex, age and whether had help (as a scribe) completing the scale, as well as time point (i.e. initial and retest). This is undertaken with a two way ANOVA with class interval (grouped level of fatigue) and the external factor (e.g. age) as main effects. Uniform DIF is then for the main effect of gender (and there is another for class interval) and non-uniform DIF is the interaction between class interval and (e.g. age).
Unidimensionality by independent t-test at the person level showing less than 5% of tests to be significant (or the lower bound of the binomial confidence interval to overlap 5%, where required) [27, 28].
Pearson correlation coefficients between item residuals less than 0.3 (local independence).
For Rasch analysis, a sample size of 243 will provide accurate estimates of item and person locations irrespective of the scale targeting . The Rasch analysis was performed using the RUMM 2020 computer software (http://www.rummlab.com). The unrestricted (partial credit) Rasch polytomous model was used with a conditional pair-wise parameter estimation . Failure of items to fit Rasch model expectations led to an iterative procedure using techniques for collapsing response categories, item deletion, and adjusting for DIF where necessary.
If data from a scale fit the Rasch model, then the summed ordinal raw scores can be considered to be sufficient to determine the level of fatigue in an individual. However, calculation of change scores can only be done with interval level data and so a conversion table of the raw ordinal score to the interval level metric, for any resultant scale, would be provided.
Comparisons of the person locations from the final scale to the summed raw scores of the FSS, VAS, and SIS were made by Spearman correlation (assuming the raw scores were non-parametric), with the expectation that these would be mild to moderate (i.e. rho between 0.3 and 0.7) in each case .
Some examples of the features of post-stroke fatigue, as described by patients, grouped according to the thematic framework derived from MS
Basically just tiredness to the point where you’re worn out. Tired. Done in.
Tiredness all the time… Its just tiredness, constant tiredness
Shattered. No energy. Whacked out. Weary.
It just takes it out your body. You just want to lie down and you’re drained.
If I do anything, you know, anything physical. Or go to the shops. Really shatters me.
I’m still not reading…I can’t concentrate on it.
It feels, sort, of, my eyes start going cos I’ve got to concentrate on the story.
motivation, energy and need to rest
If I know I’ve got something to do, I’m quite happy to get on and do it. But if I know its not that day then I’m tired and I can’t be bothered doing it…
But my fatigue is, when I get home here in my bedroom, I sort of give in then
ll take my son to school, get back in the car and go home and I’ll go straight back to bed for a few hours. But if I’m busy of a morning, I’ll go to bed at lunchtime
Sleep and behavioural response
I’m really tired and just want to go to bed and sleep and not bother with anything
Yes, well then the tiredness takes over. Basically I want to stay sitting down then and I’m weary
Sometimes you feel like when you do get up you’re tired more’
Subjects and non-responder analysis
284 packs were returned and two were discarded because of evidence of substantial visual field defect. This gave a 28.2% (282/999) response, sufficient for the Rasch analyses. The demographic details and disease characteristics are given in Table 2. Indication of the functional consequence of stroke is also given. The median SIS score was 17 which equates to a Modified Rankin Score  of 2 (slight disability) , but a full range of disability was observed, for instance subjects with severe disability of both upper and lower limb function were represented (see Table 2 for frequencies). The VAS fatigue scores were normally distributed (skewness -0.25, kurtosis -0.39) with median and modal values both of 5 cm. The distribution of the FSS revealed a substantial ceiling effect of 7.1%. Histograms of the VAS, FSS and SIS can be found in the supplemental material.
Characteristics of subjects both completing the pack and non-responders
mean age at questionnaire completion (SD, range)
67.3 (13.4, 18–95)
mean age at onset of last stroke (SD, range)
66.5 (12.4, 18–93)
70.9 (12.8, 16–102)
mean months post stroke (SD, range)
17.2 (11.4, 2–50)
previous stroke (%)
previous TIA (%)
ischaemic stroke (%)
median Stroke Impact Scale score (range)
very difficult or unable to climb one flight of stairs (%)
very difficult or unable to dress top half of body (%)
very difficult or unable to control bladder (%)
very difficult or unable to transfer from bed to chair (%)
76 records were available for the retest analysis.
The non-responders, when compared to the responders, were slightly older with a mean age difference of 4.4 year (95% CI 2.6–6.2, p < 0.001). A greater proportion were female (53% vs. 38%, p < 0.001) and had suffered more than one stroke (21% vs. 10%, p < 0.001) but there was no difference in previous TIA (p = 0.062) or type of stroke (p = 0.334). None of the differences were considered to be extreme or confound the validity of the Rasch analysis.
Summary Fit Statistics for Rasch analyses
Physical (8 items)
Cognitive (4 items)
Summary (10 items)
Diurnal – Initial (6 items)
Diurnal – Final (5 items)
Nocturnal Sleep (5 items)
< 5.0% (Lower CI)
The sleep scales were more problematic. The Diurnal sleep scale failed to meet model expectations (Table 3, Analysis 4). The item ‘I try to get everything done in the morning’ showed misfit, with a significant Chi-Square statistic, and the item set displayed multidimensionality (7.72%; CI 5.1-10.4%). Removal of this item improved fit, and resulted in a unidimensional scale (Table 3, Analysis 5). However, the item residual standard deviation, at 1.783, indicated some continuing misfit caused by another item with a high negative fit residual, indicating redundancy. The Nocturnal sleep subscale failed to fit the model (Table 3, Analysis 6), and no solution could be found.
External construct validity
Comparison of the person locations from the Physical, Cognitive and Summary Scales to the FSS gave Spearman correlation coefficients of 0.604, 0.509 and 0.622 respectively. Likewise, to the VAS, 0.556, 0.385 and 0.534 respectively, and to the SIS of 0.615, 0.532 and 0.628 respectively.
Test-retest correlation coefficients of the Physical, Cognitive and Summary Scales were 0.903, 0.786 and 0.896 respectively. There were no significant differences in the mean scores at the two time points. Analysis of DIF by time showed that the Physical, Cognitive and Summary scales were invariant between the initial and retest time points.
Raw score to interval scale conversion
Raw score to interval scale conversion table for the scales
Qualitative construct validation in adapting scales to a different diagnosis is novel. By testing the construct equivalence from the current sample against the original qualitative analysis from people with MS, the manifestation of post-stroke fatigue appeared to be qualitatively similar to that of MS fatigue, including, for example, features associated with physical and cognitive aspects . The NFI-Stroke reflects these components, and provides a simple scale of fatigue that satisfies the strictest measurement standards, supporting the internal construct validity of the scale. The substantive correlations (>0.5) with the comparator measures provide strong evidence of the external validity of the scale, with slightly stronger correlations with the physically orientated domains of the FSS and SIS. The lower correlation of the cognitive scale with the VAS possibly reflects the choice of anchors for the latter which were necessarily concise and may not have conveyed the nuances of cognitive fatigue.
The qualitative similarity between post-stroke fatigue and MS fatigue and indeed the facility with which fatigue in the two conditions could be measured on a common metric is notable given the obvious differences in pathophysiology between the two diseases. This paradox may be a potentially important starting point for future pathophysiological enquiry.
The raw score from the NFI-Stroke components is a sufficient statistic such that a simple summed score can provide an ordinal estimate of the persons (component) level of fatigue. It also can provide a straightforward ordinal to interval scale transformation, courtesy of a special property of the Rasch model [24, 33].
There were a number of limitations to the study. For example, the sample was restricted to those with a disease duration of 4 years from their most recent stroke; this was mainly determined by the age of the stroke register from which the sample was drawn. Fatigue seems to increase in the first twelve months  following stroke but is known to persist for more than two years  and so four years was felt to be an adequate disease duration for the current sample.
Subjects had to be cognitively able to interpret and respond to the scale. Further validation of the NFI-Stroke might involve clinician administration to patients with cognitive deficits.
The qualitative stroke sample was predominantly female and it could be argued that equivalence of the thematic structure to MS was confounded by sex bias. However, no sex differences were found in the MS qualitative analysis  and in the current Rasch analysis, all items were free from DIF by sex.
The non-response level of the study was also high and older patients with multiple strokes appeared to have been underrepresented. Respondents with low levels of disability were well represented. However some respondents had very high SIS scores suggesting that those with higher disability were not wholly excluded. In addition, the VAS scores were normally distributed suggesting those with extreme levels of fatigue (both low and high) were captured. Nevertheless, representativeness is not a requirement for Rasch analysis as, for example, item difficulty estimates are independent of the distribution of the sample of persons . The fact that the Summary Scale was adequately targeted to the sample, and that the sample covered a wide range of those with low to high fatigue is more important with respect to the construction of a measure than the sample’s representative nature. It should be remembered that patients were being presented with a whole pack of different scales and demographic questions which may have contributed to inflation of the non-response rate. The NFI-Stroke is a brief scale with straightforward and concise items. This format is in-keeping with other self-report scales used in neurologic disease, including stroke, and so there was minimal concern that non-response was due to some deterrent intrinsic to the structure of the NFI-Stroke.
There was one item in the Cognitive scale (coordination gets worse) with a slightly high negative fit residual which indicated a degree of redundancy and accounted for the inflated overall item residual standard deviation. The scale was not discarded because all other fit statistics were acceptable and the retention of a comparable cognitive fatigue scale between stroke and MS was felt to be desirable. Additionally, the same item had satisfactory fit within the Summary scale, albeit with the lowest chi square probability.
The sleep scales were found to be less than optimal. This was also the case in the context of MS, and thus remains a challenge for measurement. Both sets of diagnostic-specific qualitative analysis supported the importance of sleep (or its disturbance) and therefore further work is required to develop the NFI sleep scales for these populations. Whether, or not, relief by diurnal sleep or rest is adaptive or consequent, remains to be determined. It is possible that diurnal sleep represents an inherent part of the pathophysiology of fatigue, but it could also be a secondary behavioural response. The Diurnal sleep scale overall fit statistics only showed a high item residual standard deviation, comparable to the Cognitive scale. However, because, even after some modification, there was persistent individual item misfit the scale was discarded. Unlike MS, the Abnormalities of Nocturnal Sleep scale could not be resolved for the current diagnostic group.
Given the interval scaling of the NFI-Stroke, the potential now exists to model the antecedent and consequent factors associated with fatigue, and the associations within the broader biopsychosocial model, using path analysis or other appropriate multivariate techniques.
The NFI-Stroke provides a brief (12 item) and easy-to-use tool for measurement of a clearly defined concept of fatigue. The scale satisfies strict Rasch model measurement requirements and, as a result, interval level scaling is available for when change scores need to be calculated. The scales have specific validation for stroke and can be used on patients of, amongst other factors, any age, or sex.
It is suggested that the scale would be useful in both a clinical setting and as an outcome measure in clinical trials. The NFI-Stroke is free for use by all state-funded healthcare organisations and not-for-profit agencies, and can be obtained, after appropriate registration, from http://www.leeds.ac.uk/medicine/rehabmed/psychometric/Scales1.htm or by contact of the authors.
RJM, CAY, MK, SD and AS contributed to the design, implementation, and analysis of the study. JFP and AT contributed to the analysis of the study. All authors contributed to the writing of the manuscript, and all approved the final version.
The authors would like to thank all the interviewees and respondents for their willingness in taking part in this study and Dave Watling and the staff of the Clinical Trials Unit, WCNN for their assistance with the mailout.
- Appelros P: Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res 2006, 29(4):329–333. 10.1097/MRR.0b013e328010c7b8View ArticlePubMedGoogle Scholar
- Skaner Y, Nilsson GH, Sundquist K, Hassler E, Krakau I: Self-rated health, symptoms of depression and general symptoms at 3 and 12 months after a first-ever stroke: a municipality-based study in Sweden. BMC Fam Pract 2007, 8: 61. 10.1186/1471-2296-8-61PubMed CentralView ArticlePubMedGoogle Scholar
- Annoni JM, Staub F, Bogousslavsky J, Brioschi A: Frequency, characterisation and therapies of fatigue after stroke. Neurol Sci 2008, 29(Suppl 2):S244-S246.View ArticlePubMedGoogle Scholar
- Lynch J, Mead G, Greig C, Young A, Lewis S, Sharpe M: Fatigue after stroke: the development and evaluation of a case definition. J Psychosom Res 2007, 63(5):539–544. 10.1016/j.jpsychores.2007.08.004View ArticlePubMedGoogle Scholar
- Winward C, Sackley C, Metha Z, Rothwell PM: A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke 2009, 40(3):757–761. 10.1161/STROKEAHA.108.527101View ArticlePubMedGoogle Scholar
- Glader EL, Stegmayr B, Asplund K: Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke 2002, 33(5):1327–1333. 10.1161/01.STR.0000014248.28711.D6View ArticlePubMedGoogle Scholar
- Park JY, Chun MH, Kang SH, Lee JA, Kim BR, Shin MJ: Functional outcome in poststroke patients with or without fatigue. Am J Phys Med Rehabil 2009, 88(7):554–558. 10.1097/PHM.0b013e3181a0dae0View ArticlePubMedGoogle Scholar
- Schwartz JE, Jandorf L, Krupp LB: The measurement of fatigue: a new instrument. J Psychosom Res 1993, 37(7):753–762. 10.1016/0022-3999(93)90104-NView ArticlePubMedGoogle Scholar
- Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3):315–325. 10.1016/0022-3999(94)00125-OView ArticlePubMedGoogle Scholar
- Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121–1123. 10.1001/archneur.1989.00520460115022View ArticlePubMedGoogle Scholar
- Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL: The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999, 85(5):1186–1196. 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-NView ArticlePubMedGoogle Scholar
- Mead G, Lynch J, Greig C, Young A, Lewis S, Sharpe M: Evaluation of fatigue scales in stroke patients. Stroke 2007, 38(7):2090–2095. 10.1161/STROKEAHA.106.478941View ArticlePubMedGoogle Scholar
- Flachenecker P, Rufer A, Bihler I, Hippel C, Reiners K, Toyka KV, Kesselring J: Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology 2003, 61(6):851–853. 10.1212/01.WNL.0000080365.95436.B8View ArticlePubMedGoogle Scholar
- Mills RJ, Young CA: A medical definition of fatigue in multiple sclerosis. QJM 2008, 101(1):49–60.View ArticlePubMedGoogle Scholar
- Mills RJ, Young CA, Pallant J, Tennant A: Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI). Health Qual Life Outcomes 2010, 8: 22. 10.1186/1477-7525-8-22PubMed CentralView ArticlePubMedGoogle Scholar
- Pope C, Ziebland S, Mays N: Qualitative research in health care. Analysing qualitative data. BMJ 2000, 320(7227):114–116. 10.1136/bmj.320.7227.114PubMed CentralView ArticlePubMedGoogle Scholar
- Likert RA: A technique for the development of attitude scales. Educat Psychol Measurement 1952, 12: 313–315. 10.1177/001316445201200214View ArticleGoogle Scholar
- Wardlaw JM, Dennis MS, Lindley RI, Sellar RJ, Warlow CP: The validity of a simple clinical classification of acute ischaemic stroke. J Neurol 1996, 243(3):274–279. 10.1007/BF00868526View ArticlePubMedGoogle Scholar
- Lerdal A, Bakken LN, Kouwenhoven SE, Pedersen G, Kirkevold M, Finset A, Kim HS: Poststroke fatigue–a review. J Pain Symptom Manage 2009, 38(6):928–949. 10.1016/j.jpainsymman.2009.04.028View ArticlePubMedGoogle Scholar
- Tseng BY, Gajewski BJ, Kluding PM: Reliability, responsiveness, and validity of the visual analog fatigue scale to measure exertion fatigue in people with chronic stroke: a preliminary study. Stroke Res Treat 2010.Google Scholar
- Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ: The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke 1999, 30(10):2131–2140. 10.1161/01.STR.30.10.2131View ArticlePubMedGoogle Scholar
- Duncan PW, Lai SM, Bode RK, Perera S, DeRosa J: Stroke Impact Scale-16: A brief assessment of physical function. Neurology 2003, 60(2):291–296. 10.1212/01.WNL.0000041493.65665.D6View ArticlePubMedGoogle Scholar
- Andrich D: Rasch models for measurement. Sage 1988.Google Scholar
- Rasch G: Probabilistic Models for Some Intelligence and Attainment Tests Chicago. Chicago: Univ; Chicago. P.; 1980.Google Scholar
- Pallant JF, Tennant A: An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007, 46(Pt 1):1–18.View ArticlePubMedGoogle Scholar
- Tennant A, Conaghan PG: The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007, 57(8):1358–1362. 10.1002/art.23108View ArticlePubMedGoogle Scholar
- Smith EV: Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002, 3(2):205–231.PubMedGoogle Scholar
- Tennant A, Pallant JF: Unidimensionality Matters! (A Tale of Two Smiths?). Rasch Measure Trans 2006, 20(1):1048–1051.Google Scholar
- Linacre JM: Sample size and item calibration stability. Rasch Measure Trans 1994, 7: 28.Google Scholar
- Choppin B: A fully conditional estimation procedure for Rasch model parameters (CSE report 196): University of California. Center for the Study of Evaluation; 1983.Google Scholar
- Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillside, NJ: Lawrence Earlbaum Associates; 1988.Google Scholar
- van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19(5):604–607. 10.1161/01.STR.19.5.604View ArticlePubMedGoogle Scholar
- Fischer GH: Rasch Models: Foundations, Recent Developments and Applications. New York: Springer; 1995.View ArticleGoogle Scholar
- Schepers VP, Visser-Meily AM, Ketelaar M, Lindeman E: Poststroke fatigue: course and its relation to personal and stroke-related factors. Arch Phys Med Rehabil 2006, 87(2):184–188. 10.1016/j.apmr.2005.10.005View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.